Skip to content

Clinical trials

Completed Phase 2 Iron Deficiencies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Iron Deficiencies Phase: Phase 2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20122
20151
20171
20181
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AMAG Pharmaceuticals, Inc.1
American Regent, Inc.1
Carleton University1
Children's Hospitals and Clinics of Minnesota1
Hospital Civil de Guadalajara1
Imperial College London1
Keryx Biopharmaceuticals1
London School of Hygiene and Tropical Medicine1
RWTH Aachen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Iron Deficiencies9
Anemia, Iron-Deficiency4
Anemia2
Renal Insufficiency, Chronic2
Acute Kidney Injury1
Familial Primary Pulmonary Hypertension1
Fibromyalgia1
Heart Failure, Systolic1
Kidney Diseases1
Psychomotor Agitation1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.